Why the study?
LNA gapmers exhibit toxicity despite high activity, necessitating additional backbone modifications to reduce toxicity.
Introduction of a sulfonamide linkage into LNA gapmers yields tolerable duplex stability and preserves RNase H activity, offering a potential strategy to reduce antisense oligonucleotide toxicity.
Should not yet change ASO design; leaves open whether sulfonamide linkages cut LNA gapmer toxicity in vivo.
Antisense oligodeoxynucleotides can bind to target RNAs and cleave them using RNase H. Despite the high activity of antisense oligodeoxynucleotides modified with locked nucleic acids (LNA) at several bases at both the 5' and 3' ends (LNA gapmer), toxicity has been reported, necessitating additional backbone modifications to reduce toxicity. In this study, we introduced a sulfonamide linkage into the LNA gapmer to elucidate its fundamental properties such as hybridization, base recognition, and induction of RNase H activity. A new chemically stable sulfonyltriazole was used as a synthetic intermediate to introduce a sulfonamide linkage between the two nucleosides. We studied the properties of the duplex of the sulfonamide-linked gapmer and target RNAs, such as melting temperature, circular dichroism, and cleavage of RNA strands by RNase H. We found that the gapmers had a lower but tolerable duplex stability with base-pair specificity and the ability to induce RNase H activity.
No takes yet. Share an insight, caveat, or question.
Seio et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: